Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.680
-0.010 (-0.37%)
Nov 14, 2025, 9:59 AM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 523.12 million as of November 13, 2025. Its market cap has decreased by -26.71% in one year.
Market Cap
523.12M
Enterprise Value
792.00M
Revenue
741.27M
Ranking
n/a
PE Ratio
15.78
Stock Price
2.68
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 523.12M, a decrease of -24.22%. That is a compound annual growth rate of -5.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 523.12M | -23.58% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.09B |
| Pro Medicus | 26.64B |
| Cochlear | 18.86B |
| Sonic Healthcare | 10.41B |
| Ramsay Health Care | 7.04B |
| Telix Pharmaceuticals | 5.29B |
| Ansell | 5.22B |
| Mesoblast | 2.96B |